Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


 Key Statistics

Ownership: Public

Web Site: Supernus Pharmaceuticals
Symbol: SUPN


 Company News
Supernus Pharmaceuticals (SUPN) To Present At June Jefferies and Co. Healthcare Conference 5/20/2015 8:36:44 AM
Supernus Pharmaceuticals (SUPN) Announces First Quarter 2015 Financial Results 5/6/2015 10:43:41 AM
Supernus Pharmaceuticals (SUPN) To Host First Quarter 2015 Earnings Conference Cal 4/22/2015 1:05:18 PM
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Sixth U.S. Patent Protecting Trokendi XR 4/3/2015 7:17:03 AM
Georges Gemayel, Ph.D., Joins Supernus Pharmaceuticals (SUPN) Board Of Directors 3/24/2015 10:19:59 AM
Supernus Pharmaceuticals (SUPN) Announces Fourth Quarter And Full Year 2014 Results 3/11/2015 7:41:52 AM
Supernus Pharmaceuticals (SUPN) To Present At March Cowen and Company Conference 2/19/2015 8:45:23 AM
Supernus Pharmaceuticals (SUPN) To Host Fourth Quarter And Full Year 2014 Earnings Conference Call 2/18/2015 7:45:47 AM
Supernus Pharmaceuticals (SUPN) Sues TWi Pharmaceuticals, Inc. For Infringement Of Oxtellar XR® Patents 1/22/2015 8:14:41 AM
Supernus Pharmaceuticals (SUPN) Sues Par Pharmaceutical Companies, Inc. (PRX) For Infringement Of Trokendi XR® Patents 1/19/2015 7:05:30 AM